PharmGKB summary: abacavir pathway

被引：10

作者：

Barbarino, Julia M. ^{[1
]}

Kroetz, Deanna L. ^{[3
]}

Altman, Russ B. ^{[1
,2
]}

Klein, Teri E. ^{[1
]}

机构：

[1] Stanford Univ, Dept Genet, Stanford, CA 94305 USA

[2] Stanford Univ, Dept Bioengn, Stanford, CA 94305 USA

[3] Univ Calif San Francisco, Dept Bioengn & Therapeut Sci, San Francisco, CA 94143 USA

来源：

PHARMACOGENETICS AND GENOMICS | 2014年 / 24卷 / 05期

关键词：

abacavir; HIV; HLA-B; HLA-B*57:01; HSP70-HOM; hypersensitivity; pharmacodynamics; pharmacogenetics; pharmacokinetics; PharmGKB; HIV-INFECTED PATIENTS; REVERSE-TRANSCRIPTASE INHIBITOR; INTERFERON PLUS RIBAVIRIN; HUMAN-LEUKOCYTE ANTIGEN-B-ASTERISK-5701; HLA-B REGION; MYOCARDIAL-INFARCTION; PEGYLATED INTERFERON; DRUG HYPERSENSITIVITY; VIROLOGICAL RESPONSE; COINFECTED PATIENTS;

D O I：

10.1097/FPC.0000000000000040

中图分类号：

Q81 [生物工程学（生物技术）]; Q93 [微生物学];

学科分类号：

071005 [微生物学]; 090105 [作物生产系统与生态工程];

摘要：

[No abstract available]

引用

页码：276 / 282

页数：7

共 53 条

[1]

The influence of abacavir and other antiretroviral agents on virological response to HCV therapy among antiretroviral-treated HIV-infected patients [J].

Amorosa, Valerianna K. ;

Slim, Jihad ;

Mounzer, Karam ;

Bruno, Christopher ;

Hoffman-Terry, Margaret ;

Dorey-Stein, Zachariah ;

Ferrara, Thomas ;

Kostman, Jay R. ;

Lo Re, Vincent, III .

ANTIVIRAL THERAPY, 2010, 15 (01) :91-99

[2]

[Anonymous], 2001, Immunobiology: The Immune System in Health and Disease

[3]

New antivirals - mechanism of action and resistance development [J].

Balzarini, J ;

Naesens, L ;

De Clercq, E .

CURRENT OPINION IN MICROBIOLOGY, 1998, 1 (05) :535-546

[4]

Early virologic failure in HIV-coinfected hepatitis C patients treated with the peginterferon-ribavirin combination - Does abacavir play a role? [J].

Bani-Sadr, Firouze ;

Denoeud, Lise ;

Morand, Patrice ;

Lunel-Fabiani, Francoise ;

Pol, Stanislas ;

Cacoub, Patrice ;

Perronne, Christian ;

Carrat, Fabrice .

JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2007, 45 (01) :123-125

[5]

Pharmacokinetics and potential interactions amongst antiretroviral agents used to treat patients with HIV infection [J].

Barry, M ;

Mulcahy, F ;

Merry, C ;

Gibbons, S ;

Back, D .

CLINICAL PHARMACOKINETICS, 1999, 36 (04) :289-304

[6]

Analysis of the frequencies of HLA-A, B, and C alleles and haplotypes in the five major ethnic groups of the United States reveals high levels of diversity in these loci and contrasting distribution patterns in these populations [J].

Cao, K ;

Hollenbach, J ;

Shi, XJ ;

Shi, WX ;

Chopek, M ;

Fernández-Viña, MA .

HUMAN IMMUNOLOGY, 2001, 62 (09) :1009-1030

[7]

Human leukocyte antigen class I-restricted activation of CD8+ T cells provides the immunogenetic basis of a systemic drug hypersensitivity [J].

Chessman, Diana ;

Kostenko, Lyudmila ;

Lethborg, Tessa ;

Purcell, Anthony W. ;

Williamson, Nicholas A. ;

Chen, Zhenjun ;

Kjer-Nielsen, Lars ;

Mifsud, Nicole A. ;

Tait, Brian D. ;

Holdsworth, Rhonda ;

Almeida, Coral Ann ;

Nolan, David ;

Macdonalds, Whitney A. ;

Archbold, Julia K. ;

Kellerher, Anthony D. ;

Marriott, Debbie ;

Mallal, Simon ;

Bharadwaj, Mandvi ;

Rossjohn, Jamie ;

McCluskey, James .

IMMUNITY, 2008, 28 (06) :822-832

[8]

Abacavir: Absolute bioavailability, bioequivalence of three oral formulations, and effect of food [J].

Chittick, GE ;

Gillotin, C ;

McDowell, JA ;

Lou, Y ;

Edwards, KD ;

Prince, WT ;

Stein, DS .

PHARMACOTHERAPY, 1999, 19 (08) :932-942

[9]

1592U89, a novel carbocyclic nucleoside analog with potent, selective anti-human immunodeficiency virus activity [J].

Daluge, SM ;

Good, SS ;

Faletto, MB ;

Miller, WH ;

StClair, MH ;

Boone, LR ;

Tisdale, M ;

Parry, NR ;

Reardon, JE ;

Dornsife, RE ;

Averett, DR ;

Krenitsky, TA .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1997, 41 (05) :1082-1093

[10]

No Association of Abacavir Use With Myocardial Infarction: Findings of an FDA Meta-Analysis [J].

Ding, Xiao ;

Andraca-Carrera, Eugenio ;

Cooper, Charles ;

Miele, Peter ;

Kornegay, Cynthia ;

Soukup, Mat ;

Marcus, Kendall A. .

JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2012, 61 (04) :441-447

← 1 2 3 4 5 6 →